Using a Real Options Approach to Achieve Manufacturing Flexibility


Good pharmaceutical investment decisions often translate into tremendous profits and market opportunities. Sanofi-Pasteur’s Dr. Guillaume Pfefer and Uriel Kusiatin, principal and co-founder of 2Value Consulting Group, outline new methods for decision-makers to get the most bang for their bucks.

Author: Guillaume Pfefer, Sanofi-Pasteur, and Uriel Kusiatin, 2Value Consulting Group  | File Type: PDF

Find more white papers on Facilities & SupportFacilty Design & Management

View all white papers»